These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30144515)

  • 1. Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer.
    Bellamkonda K; Satapathy SR; Douglas D; Chandrashekar N; Selvanesan BC; Liu M; Savari S; Jonsson G; Sjölander A
    Cancer Lett; 2018 Nov; 437():13-24. PubMed ID: 30144515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteinyl leukotriene receptor 1 promotes 5-fluorouracil resistance and resistance-derived stemness in colon cancer cells.
    Satapathy SR; Sjölander A
    Cancer Lett; 2020 Sep; 488():50-62. PubMed ID: 32474153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer.
    Savari S; Liu M; Zhang Y; Sime W; Sjölander A
    PLoS One; 2013; 8(9):e73466. PubMed ID: 24039952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer.
    Osman J; Bellamkonda K; Liu Q; Andersson T; Sjölander A
    Anticancer Res; 2019 Apr; 39(4):1719-1728. PubMed ID: 30952711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
    Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
    Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis.
    Zovko A; Yektaei-Karin E; Salamon D; Nilsson A; Wallvik J; Stenke L
    Oncol Rep; 2018 Aug; 40(2):902-908. PubMed ID: 29845257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteinyl leukotriene receptor 1 antagonism prevents experimental abdominal aortic aneurysm.
    Di Gennaro A; Araújo AC; Busch A; Jin H; Wågsäter D; Vorkapic E; Caidahl K; Eriksson P; Samuelsson B; Maegdefessel L; Haeggström JZ
    Proc Natl Acad Sci U S A; 2018 Feb; 115(8):1907-1912. PubMed ID: 29432192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling.
    Lai J; Mei ZL; Wang H; Hu M; Long Y; Miao MX; Li N; Hong H
    Neurochem Int; 2014 Sep; 75():26-31. PubMed ID: 24879954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrus agglutinin stimulates BMP-2-dependent differentiation through autophagic degradation of β-catenin in colon cancer stem cells.
    Panda PK; Naik PP; Praharaj PP; Meher BR; Gupta PK; Verma RS; Maiti TK; Shanmugam MK; Chinnathambi A; Alharbi SA; Sethi G; Agarwal R; Bhutia SK
    Mol Carcinog; 2018 May; 57(5):664-677. PubMed ID: 29457276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer.
    Wang R; Wei J; Zhang S; Wu X; Guo J; Liu M; Du K; Xu J; Peng L; Lv Z; You W; Xiong Y; Fu Z
    Oncotarget; 2016 Dec; 7(52):86816-86828. PubMed ID: 27894099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast Induces Apoptosis-Inducing Factor-Mediated Cell Death of Lung Cancer Cells.
    Tsai MJ; Chang WA; Tsai PH; Wu CY; Ho YW; Yen MC; Lin YS; Kuo PL; Hsu YL
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montelukast modulates lung CysLT(1) receptor expression and eosinophilic inflammation in asthmatic mice.
    Zhang YJ; Zhang L; Wang SB; Shen HH; Wei EQ
    Acta Pharmacol Sin; 2004 Oct; 25(10):1341-6. PubMed ID: 15456537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
    Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
    Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cysteinyl leukotriene receptor-1 antagonists in treatment of experimentally induced mammary tumor: does montelukast modulate antitumor and immunosuppressant effects of doxorubicin?
    El-Sisi Ael-D; Sokar SS; Salem TA; Abu Risha SE
    Toxicol Ind Health; 2015 Nov; 31(11):1024-36. PubMed ID: 26499992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
    Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
    Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
    Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
    Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
    Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-suppressive effect of oestrogen receptor β in colorectal cancer patients, colon cancer cells, and a zebrafish model.
    Topi G; Satapathy SR; Dash P; Fred Mehrabi S; Ehrnström R; Olsson R; Lydrup ML; Sjölander A
    J Pathol; 2020 Jul; 251(3):297-309. PubMed ID: 32333795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.